Last updated: August 9, 2025
Introduction
Patents granted under the World Intellectual Property Organization (WIPO), particularly via the Patent Cooperation Treaty (PCT), represent critical benchmarks in drug innovation, offering insight into strategic claim coverage and the evolving patent landscape. Patent WO2018106729 exemplifies such filings in the pharmaceutical domain, often indicating a priority focus on novel therapeutic substances or formulations. This report provides a comprehensive analysis of WO2018106729's scope and claims, contextualized within the global patent landscape, to inform stakeholders and decision-makers in pharmaceutical R&D and IP strategy.
Patent Overview and Publication Details
WO2018106729 was published on July 5, 2018, with inventors and applicants linked to entities engaged in drug development, suggestive of a novel pharmaceutical compound or formulation. While the specific technical field appears to revolve around medicinal chemistry or therapeutic agents, the detailed description and claims are crucial for unraveling the patent's strategic breadth.
Scope of the Patent
The scope of WO2018106729, as defined primarily by its claims, determines the legal boundaries of the patent rights. It appears to encompass:
- Novel chemical entities or derivatives relevant for a specific therapeutic indication, possibly targeting recent unmet medical needs.
- Pharmaceutical compositions comprising the claimed compounds, including formulations with excipients, delivery systems, or carriers.
- Method of use or treatment protocols using the claimed compounds for particular diseases or conditions, such as oncology, autoimmune disorders, or infectious diseases.
- Process claims related to the synthesis or purification of the active compounds, underscoring manufacturing considerations.
The scope is likely designed to cover not only the specific compounds disclosed but also their salts, stereoisomers, enantiomers, and derivatives that retain the therapeutic efficacy.
Claims Analysis
A detailed examination of the claims reveals the following:
Independent Claims
Typically, independent claims define the core invention. For WO2018106729, they probably include:
- chemical structure claim(s) covering the novel compound(s), expressed through a Markush formula that encompasses various substitutions.
- Use claims for methods of treating particular diseases using the compound(s).
- Pharmaceutical composition claims combining the active ingredient with pharmaceutically acceptable carriers.
Dependent Claims
Dependent claims narrow the scope to specific embodiments, such as:
- Particular substitutions on the core structure that optimize pharmacokinetics or safety.
- Specific formulation types, like sustained-release tablets or injectable solutions.
- Sterioisomeric or enantiomeric variants of the compounds.
- Details related to synthesis pathways, emphasizing efficiency or purity.
Key Claim Features
- Broadness: The claim language suggests an effort to secure a broad monopoly over classes of compounds rather than a single molecule—a typical strategy in high-value drug patents.
- Scope for derivatives: Inclusion of salts, esters, and polymorphs indicates thorough coverage to prevent workarounds.
- Therapeutic claims: Use of the claimed compounds for particular indications, which extend patent rights into the method-of-use domain.
Infringement and Validity Considerations
The breadth of claims must be balanced against potential prior art. Claims overly broad or covering known chemical scaffolds could face validity challenges, while too narrow claims risk ease of design-around by competitors. The applicant likely navigated this by combining chemical novelty with specific utility claims.
Patent Landscape Context
Global Patent Filing Trends
The filing strategy mirrors standard practices in the pharmaceutical industry, where applicants seek broad territorial protection via PCT filings to extend rights across jurisdictions—United States, Europe, China, Japan, etc. Notable points include:
- Focus on emerging targets—if the compound targets a novel or less-explored pathway, this enhances commercial value.
- Patent families associated with WO2018106729 may include filings in national phase applications, extending the patent's effective scope.
- Compatibility with existing patents—careful drafting is likely in WO2018106729 to avoid infringement issues and establish freedom-to-operate.
Related Art and Patentability
Key references in the prior art landscape include:
- Existing patents on similar chemical scaffolds.
- Previous applications targeting analogous therapeutic areas.
- Known synthetic methods or polymorphs.
The applicant’s approach probably involved structural modifications that distinguish the compound sufficiently to overcome novelty and inventive step hurdles.
Competitive Landscape
In the pharmaceutical patent space, similar compounds or formulations are often protected by overlapping patents. The strategic value of WO2018106729 hinges on:
- Its novelty over prior art.
- The breadth of claims relative to existing patents.
- Possibility of licensing or cross-licensing arrangements.
Enforcement and Commercialization
The patent's enforceability depends upon jurisdictional grant and subsequent litigations or patent oppositions. The applicant must actively monitor and defend the patent against infringing entities, especially if the compound advances into clinical phases or commercialization.
Implications for Stakeholders
- Innovators can leverage WO2018106729’s scope to secure exclusive rights for their derivatives or formulations.
- Competitors may analyze the claims to design around or challenge the patent, considering prior arts or patentability issues.
- investors and licensing entities evaluate the patent’s robustness to inform licensing negotiations or strategic alliances.
Key Takeaways
- Claim Breadth: WO2018106729’s claims likely cover a broad class of chemical compounds, their formulations, and therapeutic uses, providing a comprehensive shield but also invoking validity scrutiny.
- Strategic Positioning: The patent underscores an emphasis on both chemical innovation and method of use, expanding commercial and legal flexibility.
- Patent Landscape: Positioned amidst a competitive milieu, the patent seeks to carve out exclusivity in a promising therapeutic niche but will require vigilant defense and strategic management.
- Innovation Scope: The breadth of derivatives and formulations indicates a forward-looking approach to mitigate workarounds while maximizing patent life-cycle value.
FAQs
1. What is the primary focus of WO2018106729?
The patent appears to protect a novel chemical compound or class of compounds with therapeutic potential, along with formulations and methods of treating specific diseases.
2. How broad are the claims within WO2018106729?
The claims likely encompass the core chemical structures, their derivatives (salts, stereoisomers), formulations, and therapeutic methods, aiming for maximum coverage.
3. How does this patent relate to the broader patent landscape?
It sits within a competitive space with patents on similar structures or targets. Its strength depends on its novelty over prior art and strategic claim drafting.
4. Can competitors develop similar drugs around this patent?
Potentially, by designing around the specific chemical structures or narrow claims, but the broad claims and derivatives coverage may pose challenges.
5. What strategic steps should patent holders consider for this patent?
Monitor market developments, enforce rights against infringing products, consider filing follow-up patents to extend coverage, and explore licensing opportunities.
References
[1] World Intellectual Property Organization. Patent WO2018106729. Published July 5, 2018.
[2] WIPO Patent Scope database.
[3] Patent Office records and cited references within WO2018106729.
